Boston Partners’s AlerisLife Inc ALR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-64,373
Closed -$554K 756
2018
Q3
$554K Sell
64,373
-1,827
-3% -$20.8K ﹤0.01% 680
2018
Q2
$993K Sell
66,200
-2,428
-4% -$31.6K ﹤0.01% 746
2018
Q1
$892K Hold
68,628
﹤0.01% 701
2017
Q4
$1.03M Buy
68,628
+23,144
+51% +$359K ﹤0.01% 714
2017
Q3
$705K Hold
45,484
﹤0.01% 732
2017
Q2
$682K Hold
45,484
﹤0.01% 712
2017
Q1
$978K Buy
45,484
+11,761
+35% +$288K ﹤0.01% 701
2016
Q4
$911K Sell
33,723
-5,016
-13% -$133K ﹤0.01% 714
2016
Q3
$740K Sell
38,739
-4,022
-9% -$86K ﹤0.01% 703
2016
Q2
$1M Buy
+42,761
New +$922K ﹤0.01% 687

Other funds holding ALR

Boston Partners's ALR Position: Q4 2018 in Review

Boston Partners sold out of AlerisLife Inc (ALR) in Q4 2018, closing a stake of 64,373 shares — an estimated $554K sold.

Boston Partners first reported a position in ALR in Q2 2016 and held it in 10 quarters. The position peaked at $1.03M in Q4 2017. 44 funds tracked by Wall St. Rank hold ALR as of Q4 2018.

  • Boston Partners reported no remaining AlerisLife Inc position as of Q4 2018 after selling out during the quarter.
  • Boston Partners sold 64,373 AlerisLife Inc shares in Q4 2018, an estimated $554K.
  • Boston Partners first reported a position in AlerisLife Inc in Q2 2016 and held it in 10 quarters.
  • Boston Partners's AlerisLife Inc position peaked at $1.03M in Q4 2017.
  • 44 funds tracked by Wall St. Rank held AlerisLife Inc as of Q4 2018.

Based on Boston Partners's 13F filing for Q4 2018, filed 7 Feb 2019.